Safety and efficacy of the Pipeline Embolization Device in 100 small intracranial aneurysms
Search for other papers by Nohra Chalouhi in
Current site
Google Scholar
PubMed
Search for other papers by Mario Zanaty in
Current site
Google Scholar
PubMed
Search for other papers by Alex Whiting in
Current site
Google Scholar
PubMed
Search for other papers by Steven Yang in
Current site
Google Scholar
PubMed
Search for other papers by Stavropoula Tjoumakaris in
Current site
Google Scholar
PubMed
Search for other papers by David Hasan in
Current site
Google Scholar
PubMed
Search for other papers by Robert M. Starke in
Current site
Google Scholar
PubMed
Search for other papers by Shannon Hann in
Current site
Google Scholar
PubMed
Search for other papers by Christine Hammer in
Current site
Google Scholar
PubMed
Search for other papers by David Kung in
Current site
Google Scholar
PubMed
Search for other papers by Robert Rosenwasser in
Current site
Google Scholar
PubMed
Search for other papers by Pascal Jabbour in
Current site
Google Scholar
PubMed
OBJECT
Flow diverters are increasingly used for treatment of intracranial aneurysms. In most series, the Pipeline Embolization Device (PED) was used for the treatment of large, giant, complex, and fusiform aneurysms. Little is known about the use of the PED in small aneurysms. The purpose of this study was to assess the safety and efficacy of the PED in small aneurysms (≤ 7 mm).
METHODS
A total of 100 consecutive patients were treated with the PED at the authors' institution between May 2011 and September 2013. Data on procedural safety and efficacy were retrospectively collected.
RESULTS
The mean aneurysm size was 5.2 ± 1.5 mm. Seven patients (7%) had sustained a subarachnoid hemorrhage. All except 5 aneurysms (95%) arose from the anterior circulation. The number of PEDs used was 1.2 per aneurysm. Symptomatic procedure-related complications occurred in 3 patients (3%): 1 distal parenchymal hemorrhage that was managed conservatively and 2 ischemic events. At the latest follow-up (mean 6.3 months), 54 (72%) aneurysms were completely occluded (100%), 10 (13%) were nearly completely occluded (≥ 90%), and 11 (15%) were incompletely occluded (< 90%). Six aneurysms (8%) required further treatment. Increasing aneurysm size (OR 3.8, 95% CI 0.99–14; p = 0.05) predicted retreatment. All patients achieved a favorable outcome (modified Rankin Scale Score 0–2) at follow-up.
CONCLUSIONS
In this study, treatment of small aneurysms with the PED was associated with low complication rates and high aneurysm occlusion rates. These findings suggest that the PED is a safe and effective alternative to conventional endovascular techniques for small aneurysms. Randomized trials with long-term follow-up are necessary to determine the optimal treatment that leads to the highest rate of obliteration and the best clinical outcomes.
ABBREVIATIONS
ICA = internal carotid artery; MCA = middle cerebral artery; mRS = modified Rankin Scale; PED = Pipeline Embolization Device; SAH = subarachnoid hemorrhage.
© Copyright 1944-2024 American Association of Neurological Surgeons